Cargando…

MicroRNA Involvement in Osteosarcoma

Osteosarcoma (OS) is the most common primary malignant bone tumor, usually arising in the long bones of adolescents and young adults. While our knowledge of the molecular pathogenesis of OS has increased in recent years, we are still far from a comprehensive understanding of the molecular mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Eisuke, Hornicek, Francis J., Duan, Zhenfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329862/ https://www.ncbi.nlm.nih.gov/pubmed/22550419 http://dx.doi.org/10.1155/2012/359739

Ejemplares similares

Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells
por: Zhang, Linlin, et al.
Publicado: (2015)

Regulation of microRNAs function by circular RNAs in human cancer
por: Han, Chao, et al.
Publicado: (2017)

The role of extracelluar matrix in osteosarcoma progression and metastasis
por: Cui, Juncheng, et al.
Publicado: (2020)

MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma
por: Lietz, Christopher E., et al.
Publicado: (2020)

Involvement and Clinical Aspects of MicroRNA in Osteosarcoma
por: Ram Kumar, Ram Mohan, et al.
Publicado: (2016)

MicroRNA-155 expression is independently predictive of outcome in chordoma
por: Osaka, Eiji, et al.
Publicado: (2015)

Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 (HMGA2) in Osteosarcoma
por: Cui, Juncheng, et al.
Publicado: (2022)

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2018)

SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma
por: Guo, Tao, et al.
Publicado: (2022)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2021)

Noncoding RNA in drug resistant sarcoma
por: Li, Xiaoyang, et al.
Publicado: (2017)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
por: Feng, Wenlong, et al.
Publicado: (2020)

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2009)

Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
por: Tang, Zhaopeng, et al.
Publicado: (2021)

Transcriptional activation of CBFβ by CDK11(p110) is necessary to promote osteosarcoma cell proliferation
por: Feng, Yong, et al.
Publicado: (2019)

Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2010)

Correction to: Transcriptional activation of CBFβ by CDK11(p110) is necessary to promote osteosarcoma cell proliferation
por: Feng, Yong, et al.
Publicado: (2019)

Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway
por: Ryu, Keinosuke, et al.
Publicado: (2010)

Role of MicroRNA-1 in Human Cancer and Its Therapeutic Potentials
por: Han, Chao, et al.
Publicado: (2014)

MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma
por: Sasaki, Ryo, et al.
Publicado: (2019)

Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential
por: Sun, Ranran, et al.
Publicado: (2016)

T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2021)

Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma
por: Golbakhsh, Mohammad Reza, et al.
Publicado: (2016)

Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma
por: Li, Xiaoyang, et al.
Publicado: (2020)

MicroRNA involvement in hepatocellular carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2008)

miR‐15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo
por: Duan, Zhenfeng, et al.
Publicado: (2016)

A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
por: Duan, Zhenfeng, et al.
Publicado: (2014)

Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets
por: Min, Li, et al.
Publicado: (2017)

NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance
por: Duan, Zhenfeng, et al.
Publicado: (2009)

Expression and role of microRNA-1271 in the pathogenesis of osteosarcoma
por: Lu, Gongbiao, et al.
Publicado: (2018)

Identification of miRNA and genes involving in osteosarcoma by comprehensive analysis of microRNA and copy number variation data
por: Luo, Tao, et al.
Publicado: (2017)

Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells
por: Liao, Yunfei, et al.
Publicado: (2017)

The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
por: Zhou, Yubing, et al.
Publicado: (2016)

Exosomes promote pre-metastatic niche formation in ovarian cancer
por: Feng, Wenlong, et al.
Publicado: (2019)

Principles of microRNA involvement in human cancers
por: Ling, Hui, et al.
Publicado: (2011)

Involvement of MicroRNA in T-Cell Differentiation and Malignancy
por: Saki, Najmaldin, et al.
Publicado: (2015)

Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
por: Liu, Tang, et al.
Publicado: (2016)

MicroRNA-143 expression inhibits the growth and the invasion of osteosarcoma
por: Zhang, Pei, et al.
Publicado: (2022)

MicroRNAs for osteosarcoma in the mouse: a meta-analysis
por: Chang, Junli, et al.
Publicado: (2016)

Role of MicroRNAs in Human Osteosarcoma: Future Perspectives
por: Llobat, Lola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8272kn85kag8kkgdfdoi9gusd